Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7499 USD | -0.01% | -3.86% | +36.35% |
May. 20 | Nuo Therapeutics, Inc. announced that it has received $0.650875 million in funding | CI |
May. 15 | Nuo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 9
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Innovative Cell-based Technologies
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +442.12% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +442.12% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Jorden
CEO | Chief Executive Officer | 61 | 08-09-18 |
Peter Clausen
COO | Chief Operating Officer | 58 | 08-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
C. Winzer
BRD | Director/Board Member | 67 | 09-01-29 |
David Jorden
CEO | Chief Executive Officer | 61 | 08-09-18 |
Paul Mintz
BRD | Director/Board Member | 75 | 17-04-06 |
Scott Pittman
BRD | Director/Board Member | 65 | 16-05-04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 45,109,349 | 18,625,106 ( 41.29 %) | 0 | 41.29 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+36.35% | 33.18M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- AURX Stock
- Company Nuo Therapeutics, Inc.